Related Experiment Video

Updated: Jul 15, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis

A J Czaja1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. czaja.albert@mayo.edu

Minerva Gastroenterologica E Dietologica
|April 7, 2007
PubMed

Insights

Autoimmune hepatitis diagnosis is improving with scoring systems and new antibody markers. While treatment decisions should focus on disease activity, not symptoms, novel therapies offer new hope for patients.

Area of Science:

  • Hepatology
  • Immunology
  • Genetics

Background:

  • Diagnostic criteria for autoimmune hepatitis (AIH) are established, with scoring systems quantifying diagnosis strength.
  • Acute disease presentations include centrilobular (zone 3) necrosis, with severe and fulminant cases recognized.
  • Asymptomatic patients may not require immediate treatment, but disease activity, not symptoms, guides therapeutic decisions.

Purpose of the Study:

  • To review current diagnostic and prognostic markers for autoimmune hepatitis.
  • To explore the immunological and genetic underpinnings of autoimmune hepatitis pathogenesis.
  • To discuss emerging therapeutic strategies and future research directions for autoimmune hepatitis.

Main Methods:

  • Review of diagnostic criteria and scoring systems for autoimmune hepatitis.
  • Analysis of prognostic antibody markers and genetic susceptibility factors.
  • Examination of immunological pathways, including T regulatory and natural killer T cells.
  • Evaluation of novel immunosuppressive agents and molecular interventions.

Main Results:

  • Specific antibodies (soluble liver antigen/liver pancreas, asialoglycoprotein receptor, actin, liver cytosol type 1) show prognostic value.
  • Genetic factors like susceptibility alleles and polymorphisms influence immune responses and disease progression.
  • Dysregulation of T regulatory and natural killer T cells contributes to immune homeostasis disruption.
  • New treatments including cyclosporine, mycophenolate mofetil, and budesonide are available.

Conclusions:

  • Autoimmune hepatitis diagnosis and prognosis are enhanced by codified criteria and specific biomarkers.
  • Understanding molecular mimicry, genetic susceptibility, and immune cell dysregulation is key to pathogenesis.
  • Emerging therapies offer improved management options, with molecular interventions showing future promise.
  • Development of robust animal models and collaborative research networks are crucial for advancing AIH understanding and treatment.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...